Latest On Axonics Modulation Technologies, Inc (AXNX):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-12 20:59 EST | News | Axonics: Attractive Strong Growth Profile | N/A |  |
| 2023-05-04 09:38 EST | News | Axonics: Q1 Fall Provides Great Entry Point | N/A | |
| 2023-05-02 07:35 EST | News | Axonics, Inc. (AXNX) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-05-01 19:38 EST | News | Axonics Modulation Technologies GAAP EPS of -$0.19, revenue of $70.7M | N/A | |
| 2023-04-24 15:54 EST | News | Axonics acquires tech linked to sacral neuromodulation procedure | N/A | |
About Axonics Modulation Technologies, Inc (AXNX):
Axonics Modulation Technologies, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct salesforce and distributors in the United States, the United Kin read more...gdom, Germany, France, Nordic countries, and internationally. The company was formerly known as American Restorative Medicine, Inc. and changed its name to Axonics Modulation Technologies, Inc. in August 2013. Axonics Modulation Technologies, Inc. was incorporated in 2012 and is headquartered in Irvine, California.
General
- Name Axonics Modulation Technologies, Inc
- Symbol AXNX
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryMedical Devices
- Full Time Employees 416
- Fiscal Year EndDecember
- IPO Date2018-10-31
- Gic SectorHealth Care
- Gic GroupHealth Care Equipment & Services
- Gic IndustryHealth Care Equipment & Supplies
- Gic SubIndustryHealth Care Equipment
- Web URLhttp://www.axonics.com
Valuation
- Price/Sales (Trailing 12 Mt.) 19.23
- Price/Book (Most Recent Quarter) 8.39
- Enterprise Value Revenue 19.75
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$1.21
- Next Year EPS Estimate -$0.51
- Next Quarter EPS Estimate -$0.37
- Profit Margin -49%
- Operating Margin -48%
- Return on Assets -12%
- Return on Equity -23%
- Revenue 111.54 million
- Earnings Per Share -$2.53
- Revenue Per Share $3.02
- Gross Profit 67.09 million
- Quarterly Earnings Growth 249.7%
Highlights
- Market Capitalization 2.31 billion
- EBITDA -48794000
- PE Ratio -2066.38
- Analyst Target Price $65.78
- Book Value Per Share $7.20
Share Statistics
- Shares Outstanding 41.52 million
- Shares Float 40.52 million
- % Held by Insiders 689%
- % Held by Institutions 112.92%
- Shares Short 4.49 million
- Shares Short Prior Month 4.7 million
- Short Ratio 7.67
- Short % of Float 14%
- Short % of Shares Outstanding 11%
Technicals
- Beta 0.01
- 52 Week High $60
- 52 Week Low $17.25
- 50 Day Moving Average 54.52
- 200 Day Moving Average 48.72
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
Axonics Modulation Technologies, Inc (AXNX) Dividend Calendar:
Axonics Modulation Technologies, Inc (AXNX) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Axonics Modulation Technologies, Inc (AXNX) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Axonics Modulation Technologies, Inc (AXNX) Chart:
Axonics Modulation Technologies, Inc (AXNX) News:
Below you will find a list of latest news for Axonics Modulation Technologies, Inc (AXNX) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Axonics Modulation Technologies, Inc (AXNX) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Latest AXNX Trades:
Axonics Modulation Technologies, Inc (AXNX) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | View |
|---|---|---|
| 2020-11-06 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-11-04 | 8-K (Current report) | |
| 2020-11-04 | 10-Q (Quarterly report [Sections 13 or 15(d)]) | |
| 2020-11-03 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-10-13 | SC 13G (Statement of acquisition of beneficial ownership by individuals) | |
| 2020-09-22 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-09-02 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-09-02 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-26 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-26 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-26 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-26 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-26 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-26 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-20 | SC 13D/A (General statement of acquisition of beneficial ownership) | |
| 2020-08-18 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-12 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-11 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-10 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-06 | 8-K (Current report) | |
Axonics Modulation Technologies, Inc (AXNX) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Axonics Modulation Technologies, Inc (AXNX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 689%
Institutional Ownership: 11292%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-11-04 | Rinda Sama | Chief Operating Officer | Sell | 2,600.00 | 50.12 | 130,313.56 | 109,964.00 | |
| 2020-11-03 | Rinda Sama | Chief Operating Officer | Sell | 300.00 | 50.00 | 15,000.00 | 112,564.00 | |
| 2020-10-30 | Rinda Sama | Chief Operating Officer | Sell | 1,100.00 | 48.54 | 53,396.97 | 112,864.00 | |
| 2020-10-30 | Rinda Sama | Chief Operating Officer | Sell | 6,037.00 | 47.81 | 288,602.41 | 113,964.00 | |
| 2020-10-29 | Rinda Sama | Chief Operating Officer | Sell | 2,863.00 | 48.60 | 139,141.80 | 120,001.00 | |
| 2020-10-29 | Rinda Sama | Chief Operating Officer | Sell | 3,800.00 | 48.12 | 182,873.86 | 122,864.00 | |
| 2020-10-29 | Rinda Sama | Chief Operating Officer | Sell | 6,200.00 | 47.71 | 295,819.98 | 126,664.00 | |
| 2020-10-29 | Rinda Sama | Chief Operating Officer | Buy | 7,373.00 | 14.19 | 104,622.87 | 127,374.00 | |
| 2020-10-29 | Rinda Sama | Chief Operating Officer | Buy | 2,627.00 | 1.63 | 4,282.01 | 130,001.00 | |
| 2020-10-29 | Rinda Sama | Chief Operating Officer | Buy | 2,863.00 | 14.19 | 40,625.97 | 132,864.00 | |
| 2020-09-18 | Bakker Juliet Tammenoms | Director | Sell | 9,167.00 | 42.67 | 391,119.22 | 3,500.00 | |
| 2020-09-02 | Alfred J Jr Ford | Chief Commercial Officer | Sell | 226.00 | 41.32 | 9,338.98 | 0.00 | |
| 2020-09-02 | Alfred J Jr Ford | Chief Commercial Officer | Sell | 23,743.00 | 40.41 | 959,364.41 | 226.00 | |
| 2020-09-02 | Alfred J Jr Ford | Chief Commercial Officer | Sell | 11,031.00 | 39.84 | 439,526.89 | 23,969.00 | |
| 2020-09-02 | Alfred J Jr Ford | Chief Commercial Officer | Buy | 35,000.00 | 1.42 | 49,700.00 | 35,000.00 | |
| 2020-08-31 | Alfred J Jr Ford | Chief Commercial Officer | Sell | 2,667.00 | 42.31 | 112,845.04 | 0.00 | |
| 2020-08-28 | John Woock | Chief Marketing Officer | Sell | 5,000.00 | 43.45 | 217,251.00 | 67,348.00 | |
| 2020-08-28 | John Woock | Chief Marketing Officer | Buy | 5,000.00 | 1.63 | 8,150.00 | 72,348.00 | |
| 2020-08-28 | John Woock | Chief Marketing Officer | Sell | 5,000.00 | 43.45 | 217,267.00 | 72,348.00 | |
| 2020-08-28 | John Woock | Chief Marketing Officer | Buy | 5,000.00 | 1.32 | 6,600.00 | 77,348.00 | |